Novocure (NVCR) Misses Q2 EPS by 8c
Get Alerts NVCR Hot Sheet
Join SI Premium – FREE
Novocure (NASDAQ: NVCR) reported Q2 EPS of ($0.23), $0.08 worse than the analyst estimate of ($0.15). Revenue for the quarter came in at $140.9 million versus the consensus estimate of $135.33 million.
For earnings history and earnings-related data on Novocure (NVCR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Sempra Energy (SRE) Tops Q3 EPS by 20c ; Offers Guidance
- Wendy's (WEN) Tops Q3 EPS by 3c
- Intensity Therapeutics, Inc. (INTS) Misses Q3 EPS by 13c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share